Coronavirus Update: After UK Nod, New Forecast Makes Pfizer Vaccine The Leader
Plus Russia Extends India Alliances
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.
You may also be interested in...
Initial $4.8bn Outlay To Back India's COVID-19 Vaccination Run
Significant allocations for public health programs and vaccination are prominent features of India's budget for fiscal 2021-22, though execution of these plans will be critical. Pharma is also keenly tracking a proposed allocation to bolster the overall research ecosystem and opening up of the insurance sector to foreign ownership.
The Race To Develop A COVID-19 Vaccine: mRNA Pioneers Lead The Way
Our updated graphic tracker of key developments from the leading vaccine candidates.
UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine
The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.